SANTHERA PHARMACEUTICALS (SCHWEIZ) AG;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
发明人:
MEIER, THOMAS,BIELEKOVA, BIBIANA,MCFARLAND, HENRY, F.
申请号：
DK09795720
公开号：
DK2424513T3
申请日:
2009.12.18
申请国别(地区):
DK
年份:
2015
代理人:
摘要：
The present invention relates to pharmaceuticals and uses thereof directed to the curative treating or preventing of Primary Progressive Multiple Sclerosis (PP-MS), by using 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (Idebenone) as the active agent.
